No Detail Found!

Beneficial synergistic effects of Canagliflozin and Zinc sulphate on diabetic dyslipidemia in diabetic rat model

Author(s)
Ayela Eman Zia Departments of Pharmacology, CMH Lahore Medical College and Institute of Dentistry, Pakistan
Sehrish Zaffar Departments of Pharmacology, CMH Lahore Medical College and Institute of Dentistry, Pakistan
Waqar Ahmed Siddiqui Departments of Pharmacology, CMH Lahore Medical College and Institute of Dentistry, Pakistan
Mahwash Malik Central Park Medical College, Pakistan
Zujaja Zaheer Sahara Medical College, Narowal, Pakistan
Bisma Fatima Aslam Azra Naheed Medical College, Lahore Pakistan
Abstract
Objective: To evaluate the effects of canagliflozin and zinc sulphate on diabetic dyslipidemia after treating a streptozotocin-induced diabetes rat model (type-2 diabetes). Methodology: This in vivo study was conducted in the Department of Pharmacology, King Edward Medical University, Lahore, Pakistan. In total, 48 male Sprague Dawley rats were divided equally to form six groups. All received a high-fatty diet during experimental study. Groups A and B were labelled as the normal and disease control. On day 22, diabetes was induced in Groups B, C, D, E, and F with 35 mg/kg streptozotocin, administered intraperitoneally as single dose. After confirming diabetes, the animals were treated orally for four weeks according to their groups with or without full dose (10 mg/kg/day) and half dose of canagliflozin (5 mg/kg/ day), alone or together with zinc sulphate (30 mg/kg/ day or 15m g/k/day). Lipid profile (serum cholesterol, serum triglycerides, serum LDL and HDL) were carried out in weeks 0, 4, and 8. Results: The combination therapy was found to be more effective as manifested by significant lowering of the values of these biochemical parameters after the tre-atment. Conclusion: Combination therapy exerted a better eff-ect on diabetic dyslipidemia as compared to the indivi-dual treatments.
Publication Details
Page(s) 487-490
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 50, Issue: 2, Year: 2025

Request the full text from PASTIC

Keywords
Diabetes, Dyslipidemia, Streptozotocin., canagliflozin, lip-id profile
References
Al-Ghadeer HA,Al-Barqi M,Al-Maqhawi A,Alsultan AS,Alghafli JA,Al-Omaish MA .2021 .Prevalence of dyslipidemia in patients with type 2 diabetes mellitus: A cross-sectional study. Cureus, 13 : 123-42.
Bruemmer D,Nissen SE .2020 .Prevention, and management of cardiovascular disease in patients with diabetes: current challenges and opportunities. Cardiovasc Endocrinol Metabol, 9 : 81-90.
Li D,Wu T,Wang T,Wei H,Wang A,Tang H .2020 .Effects of sodium glucose cotransporter 2 inhibitors on risk of dyslipidemia among patients with type 2 diabetes: A systematic review and meta‐analysis of randomized controlled trials. Pharm Epidemiol Drug Saf, 29 : 582-90.
Jafarnejad S,Mahboobi S,McFarland LV,Taghizadeh M .2019 .Meta-analysis: effects of zinc supplementation alone or with multi-nutrients on glucose control and lipid levels in patients with type 2 diabetes. Prev Nutr Food Sci, 24 : 8-21.
Dybiec J,Baran W,Dąbek B,Fularski P,Młynarska E,Radzioch E .2023 .Advances in the treatment of dyslipidemia. Int J Mol Sci, 24 : 132-88.
Geng Q,Hou F,Zhang Y,Wang Z,Zhao M. .2022 .Effects of different doses of canagliflozin on blood pressure and lipids in patients with type 2 diabetes: a meta-analysis. J Hyper, 40 : 996-1001.
Kutoh E,Kuto AN,Wada A,Kurihara R,Kojima R .2022 .Regulations of free fatty acids and diabetic parameters in drug naïve subjects with type 2 diabetes treated with canagliflozin monotherapy. Drug Res, 72 : 86-93.
Nazarizadeh A,Asri-Rezaie S A .2016 .Comparative study of antidiabetic activity and oxidative stress induced by zinc oxide nanoparticles and zinc sulfate in diabetic rats. AAPS Pharm Sci Tech, 17 : 834-43.
Maulidia M,Wibowo JW,Sumarawati T,Decrease LDL .2022 .and IL-6 in Hyper cholesterol Male Wistar Rats. Indonesian J Med, 7 : 471-8.
Marie M,Arafa N .2015 .Sara Abdullah Mubarak A. Effect of canagliflozin or metformin on metabolic disorders in obese diabetic rats. Afr J Pharm Pharmacol, 9 : 1071-9.
Huang H,Liao D,Dong Y,Pu R .2020 .Effect of quercetin supplementation on plasma lipid profiles, blood pressure, and glucose levels: a systematic review and meta-analysis. Nutr Rev, 78 : 615-26.
Nelson AJ,Rochelau SK,Nicholls SJ .2018 .Managing dyslipidemia in type 2 diabetes. Endocrinol Metab Clin North Am, 47 : 153-73.
Seyedmahalleh MH,Montazer M,Ebrahimpour-Koujan S,Azadbakht L .2023 .The effect of zinc supplementation on lipid profiles in type-2 diabetes mellitus patients: a systematic review and dose-response meta-analysis of randomized clinical trials. Advan Nutr, 34 : 321-33.
Shamardl H,Sadek S,Ahmed A .2023 .Assessment of SGLT2 Inhibitor, Canagliflozin Effects on Metabolic SyndromeInduced Cardiovascular Disorders in Rats. Fay Univ Med J, 12 : 84-94.
Attia H,Al-Rasheed N,Faddah L .2015 .The combination of zinc and glibenclamide limits cardiovascular complications in diabetic rats via multiple mechanisms. Pak J Pharm Sci, 28 : 489-98.
0

Citations

0

Downloads

56

Views